|
FAM200B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.03989999955934E-07 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.899900E-02 |
| Stage1-vs-Stage3 |
1.190840E-01 |
| Stage1-vs-Stage4 |
1.038500E-03 |
| Stage2-vs-Stage3 |
1.946080E-02 |
| Stage2-vs-Stage4 |
3.042900E-04 |
| Stage3-vs-Stage4 |
5.401500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.68790000004893E-06 |
| Normal-vs-Asian |
5.12767606153375E-12 |
| Caucasian-vs-AfricanAmerican |
5.778400E-01 |
| Caucasian-vs-Asian |
6.052400E-01 |
| AfricanAmerican-vs-Asian |
7.871000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97619698383278E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.162800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
2.1094237467878E-15 |
| Normal-vs-Age(61-80Yrs) |
1.64246394263046E-12 |
| Normal-vs-Age(81-100Yrs) |
5.765400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.849600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.940600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.495000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.189200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.288200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.375000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.596480E-03 |
| Classical-VS-Follicular |
9.6655000000001E-05 |
| Classical-VS-Other |
8.484400E-02 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.65989999967309E-07 |
| Tall-VS-Other |
3.116400E-03 |
| Tall-VS-Normal |
1.63324909152607E-12 |
| Follicular-VS-Other |
9.234800E-01 |
| Follicular-VS-Normal |
9.50859999959697E-07 |
| Other-VS-Normal |
2.726100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.57571741713036E-13 |
| Normal-vs-N1 |
9.35918009759007E-14 |
| N0-vs-N1 |
3.688400E-02 |
|
|
